USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like Video: What is the Future of Additive Manufacturing? July 10, 2018 RBI had ‘carpe diem’ moment in last policy meet: HSBC April 12, 2017 Festive season sales chequered across categories October 18, 2017